Evidence map›Paper›PMID 29649747›Full record

ArticleBiomaterials2018

Polymeric micelles: Theranostic co-delivery system for poorly water-soluble drugs and contrast agents.

Jaydev R Upponi, Kaushal Jerajani, Dattatri K Nagesha, Praveen Kulkarni, Srinivas Sridhar, Craig Ferris, Vladimir P Torchilin

Abstract read
In one paragraph

Article in Biomaterials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 103 citations in OpenAlex.

  1. Review
  2. Article
  3. Mannose Ligands for Mannose Receptor Targeting.International journal of molecular sciences · 2024
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Magnetic Nanoparticles as MRI Contrast Agents.Topics in current chemistry (Cham) · 2020
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jaydev R UpponiCenter for Pharmaceutical Biotechnology & Nanomedicine, Department of Pharmaceutical Sciences, Northeastern University, 140 The Fenway, Boston, MA 02115, USA.
Kaushal JerajaniCenter for Pharmaceutical Biotechnology & Nanomedicine, Department of Pharmaceutical Sciences, Northeastern University, 140 The Fenway, Boston, MA 02115, USA.
Dattatri K NageshaElectronic Materials Research Institute, Department of Physics, Northeastern University, 360 Huntington Ave, Boston, MA 02115, USA.
Praveen KulkarniCenter for Translational NeuroImaging, Department of Pharmaceutical Sciences, Northeastern University, 360 Huntington Ave, Boston, MA 02115, USA.
Srinivas SridharElectronic Materials Research Institute, Department of Physics, Northeastern University, 360 Huntington Ave, Boston, MA 02115, USA.
Craig FerrisCenter for Translational NeuroImaging, Department of Pharmaceutical Sciences, Northeastern University, 360 Huntington Ave, Boston, MA 02115, USA.
Vladimir P TorchilinCenter for Pharmaceutical Biotechnology & Nanomedicine, Department of Pharmaceutical Sciences, Northeastern University, 140 The Fenway, Boston, MA 02115, USA. Electronic address: v.torchilin@neu.edu.
Northeastern University · US

Funding

Physico-Chemical Nanocharacterization CoreU54CA151881 · NCI · NORTHEASTERN UNIVERSITY · PI SRIDHAR, SRINIVAS · 2010 to 2014
$12.4M
MULTIFUNCTIONAL STIMULI-SENSITIVE PHARMACEUTICAL NANOCARRIERSR01CA121838 · NCI · NORTHEASTERN UNIVERSITY · PI TORCHILIN, VLADIMIR P · 2006 to 2010
$1.4M
NCI NIH HHS R01 CA121838NCI NIH HHS U54 CA151881
6 · The paper itself

Abstract

Interest in theranostic agents has continued to grow because of their promise for simultaneous cancer detection and therapy. A platform-based nanosized combination agent suitable for the enhanced diagnosis and treatment of cancer was prepared using polymeric polyethylene glycol-phosphatidylethanolamine-based micelles loaded with both, poorly soluble chemotherapeutic agent paclitaxel and hydrophobic superparamagnetic iron oxide nanoparticles (SPION), a Magnetic Resonance Imaging contrast agent. The co-loaded paclitaxel and SPION did not affect each other's functional properties in vitro. In vivo, the resulting paclitaxel-SPION-co-loaded PEG-PE micelles retained their Magnetic Resonance contrast properties and apoptotic activity in breast and melanoma tumor mouse models. Such theranostic systems are likely to play a significant role in the combined diagnosis and therapy that leads to a more personalized and effective form of treatment.

Indexed as

Drug Delivery SystemsMicellesAnimalsApoptosisCell Line, TumorContrast MediaFemaleMagnetic Resonance ImagingMagnetite NanoparticlesMaleMice, Inbred BALB CMice, Inbred C57BLNeoplasmsPaclitaxelPolymersSolubilityContrast MediaMagnetite NanoparticlesMicellesPaclitaxelPolymersWaterCancer therapyDiagnosticsDrug deliveryMicellesNanoparticlesTheranostics

Identifiers

PMID29649747
PMCPMC5918157
OpenAlexW2794954838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.